Analyst Downgraded Stocks on the NAS April 2025

April 03, 2025

Analyst Downgrades

Companies are downgraded when at least one analyst has downgraded their view on the stock, therefore decreasing its average consensus value. Companies can get downgraded for a number of reasons but primarily due to reduced future earnings potential due to loss of contracts, faltering product lines, increasing costs relative to revenue or financial risk.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

About the Data

This table includes the number of analyst ratings along with the number of buy-hold-sells on the company. A company is included in this list when its mean rating decreases from the previous week.

How do you use this table?

Companies that have recently been downgraded are viewed as having potential future losses. Use this table as a starting point for further research on these companies. Stocks with analyst coverage also tend to have higher visibility in the marketplace, therefore have the potential to be more liquid. Stocks in this category are generally sold to preserve capital or held as a short position.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameBuyOutperformHoldUnderperformSellNo OpinionMean RatingPrev Mean LabelMean Label
LULU Lululemon Athletica Inc 2 0 4 0 0 0 3.7 4.0 Outperform
GMAB Genmab AS 3 0 0 0 1 0 4.0 4.5 Outperform
All data provided as at market close March 31, 2025.

Company Details

Lululemon Athletica Inc

LULU:NAS

Buy

2

Hold

4

Mean Rating

3.7

Prev Mean Rating

4.0

Mean Label

Outperform

Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment.

Access the stockcalc valuation


Genmab AS

GMAB:NAS

Buy

3

Sell

1

Mean Rating

4.0

Prev Mean Rating

4.5

Mean Label

Outperform

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product.

Access the stockcalc valuation


Analysts downgraded Lululemon Athletica and Genmab on the NAS this month. See the full list of analyst downgrades on the blog: https://www.stockcalc.com/Blog/analyst-downgraded-stocks-nas-april-2025
Lululemon Athletica $LULU and Genmab $GMAB downgraded on the #NAS this month. See the full list of downgrades: https://www.stockcalc.com/Blog/analyst-downgraded-stocks-nas-april-2025
Analysts downgraded Lululemon Athletica and Genmab on the NAS this month. See the full list of analyst downgrades on the blog: https://www.stockcalc.com/Blog/analyst-downgraded-stocks-nas-april-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.